Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/3434

TR 354 Rat Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                            DIMETHOXANE


NTP Experiment-Test: 05038-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/05/94
Route: GAVAGE                                                                                                     Time: 07:33:28




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  828-00-2

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05038-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            DIMETHOXANE                                        Date: 09/05/94  
Route: GAVAGE                                                                                                     Time: 07:33:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      125 MG/      250 MG/                                                
                                                                KG           KG                                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60                                                  
  Scheduled Sacrifice                                 10           10           10                                                  
  Early Deaths                                                                                                                      
    Moribund                                          12           13           13                                                  
    Dead                                               6            3            2                                                  
    Dosing Accident                                    2            3           11                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                30           31           24                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (50)                                                
      Foreign Body                                     1 (2%)                                                                       
      Hemorrhage, Acute                                1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                    3 (6%)                                             
      Perforation                                                                1 (2%)                                             
   Intestine Large, Cecum                             (44)         (47)         (45)                                                
      Concretion                                                                 1 (2%)                                             
      Inflammation, Chronic Active                                               1 (2%)                                             
      Parasite Metazoan                                             1 (2%)       1 (2%)                                             
   Intestine Large, Colon                             (48)         (50)         (50)                                                
      Diverticulum                                     1 (2%)                                                                       
      Parasite Metazoan                                             1 (2%)       4 (8%)                                             
   Intestine Large, Rectum                            (47)         (47)         (46)                                                
      Parasite Metazoan                                4 (9%)       4 (9%)       2 (4%)                                             
   Liver                                              (50)         (49)         (50)                                                
      Basophilic Focus                                40 (80%)     35 (71%)     34 (68%)                                            
      Clear Cell Focus                                 3 (6%)       3 (6%)       3 (6%)                                             
      Degeneration, Cystic                                          1 (2%)                                                          
      Eosinophilic Focus                                                         1 (2%)                                             
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Hepatodiaphragmatic Nodule                       6 (12%)                   4 (8%)                                             
      Inflammation, Chronic                           23 (46%)     18 (37%)     21 (42%)                                            
      Inflammation, Necrotizing                                                  1 (2%)                                             
      Necrosis, Coagulative                            1 (2%)                                                                       
      Vacuolization Cytoplasmic                                     2 (4%)                                                          
   Mesentery                                          (47)         (46)         (49)                                                
      Inflammation, Chronic Active                     2 (4%)       1 (2%)       1 (2%)                                             
      Mineralization                                   1 (2%)                                                                       
   Pancreas                                           (50)         (50)         (50)                                                
      Acinus, Atrophy                                 14 (28%)     19 (38%)     12 (24%)                                            
   Salivary Glands                                    (48)         (50)         (49)                                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05038-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            DIMETHOXANE                                        Date: 09/05/94  
Route: GAVAGE                                                                                                     Time: 07:33:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      125 MG/      250 MG/                                                
                                                                KG           KG                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Acinus, Atrophy                                  1 (2%)                                                                       
      Duct, Hyperplasia                                1 (2%)                                                                       
   Stomach, Forestomach                               (50)         (50)         (50)                                                
      Acanthosis, Diffuse                                                        3 (6%)                                             
      Acanthosis, Focal                                             8 (16%)     41 (82%)                                            
      Hyperkeratosis, Diffuse                                                   10 (20%)                                            
      Hyperkeratosis, Focal                                         5 (10%)     12 (24%)                                            
      Hyperplasia, Focal                                            1 (2%)       3 (6%)                                             
      Inflammation, Chronic Active                     1 (2%)       3 (6%)                                                          
      Ulcer                                                         3 (6%)                                                          
   Stomach, Glandular                                 (50)         (49)         (50)                                                
      Inflammation, Chronic Active                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (49)         (50)         (50)                                                
      Inflammation, Chronic Active                                               1 (2%)                                             
   Heart                                              (50)         (50)         (50)                                                
      Bacterium, Multiple                                           1 (2%)       1 (2%)                                             
      Cardiomyopathy, Chronic                         37 (74%)     33 (66%)     32 (64%)                                            
      Foreign Body                                                  1 (2%)       2 (4%)                                             
      Infarct                                                       1 (2%)                                                          
      Inflammation, Chronic Active                                  3 (6%)       6 (12%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (50)         (50)                                                
      Degeneration, Fatty                              3 (6%)      13 (26%)      7 (14%)                                            
      Hyperplasia                                     17 (34%)     20 (40%)     18 (36%)                                            
      Hypertrophy                                      1 (2%)                    1 (2%)                                             
      Necrosis, Coagulative                                         1 (2%)       4 (8%)                                             
   Adrenal Gland, Medulla                             (50)         (50)         (49)                                                
      Hyperplasia                                      5 (10%)      5 (10%)      8 (16%)                                            
   Parathyroid Gland                                  (46)         (43)         (42)                                                
      Cyst                                                          1 (2%)                                                          
      Hyperplasia                                                   2 (5%)                                                          
   Pituitary Gland                                    (48)         (49)         (50)                                                
      Pars Distalis, Cyst                             19 (40%)     21 (43%)     28 (56%)                                            
      Pars Distalis, Hemorrhage, Acute                 1 (2%)                                                                       
      Pars Distalis, Hyperplasia                      20 (42%)     18 (37%)     15 (30%)                                            
      Pars Distalis, Pigmentation, Hemosiderin                                   4 (8%)                                             
      Pars Intermedia, Cyst                                         1 (2%)                                                          
   Thyroid Gland                                      (50)         (50)         (50)                                                
      Hemorrhage, Chronic                                                        1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05038-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            DIMETHOXANE                                        Date: 09/05/94  
Route: GAVAGE                                                                                                     Time: 07:33:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      125 MG/      250 MG/                                                
                                                                KG           KG                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Inflammation, Chronic Active                                               2 (4%)                                             
      C-Cell, Hyperplasia                             26 (52%)     24 (48%)     27 (54%)                                            
      Follicle, Cyst                                                1 (2%)                                                          
      Follicular Cell, Hyperplasia                                  1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (47)         (46)         (48)                                                
      Fibrosis                                                                   1 (2%)                                             
      Hyperplasia                                      5 (11%)      7 (15%)      2 (4%)                                             
      Inflammation, Chronic Active                     1 (2%)       3 (7%)       7 (15%)                                            
      Necrosis, Caseous                                             2 (4%)                                                          
      Duct, Dilatation                                              2 (4%)                                                          
   Ovary                                              (50)         (49)         (50)                                                
      Atrophy                                                       3 (6%)       1 (2%)                                             
      Cyst                                             3 (6%)       4 (8%)       2 (4%)                                             
   Uterus                                             (50)         (49)         (50)                                                
      Dilatation                                       5 (10%)      5 (10%)      2 (4%)                                             
      Diverticulum                                                               1 (2%)                                             
      Hemorrhage                                       2 (4%)       1 (2%)                                                          
      Inflammation, Chronic Active                                               3 (6%)                                             
      Prolapse                                         1 (2%)                                                                       
      Endometrium, Hyperplasia, Cystic, Glandular      2 (4%)       6 (12%)      8 (16%)                                            
   Vagina                                             (2)                       (1)                                                 
      Inflammation, Chronic Active                                               1 (100%)                                           
      Prolapse                                         1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)                                                
      Femoral, Hyperplasia, Reticulum Cell             5 (10%)      1 (2%)       2 (4%)                                             
   Lymph Node                                         (50)         (50)         (50)                                                
      Inguinal, Cyst                                   1 (2%)                                                                       
      Mediastinal, Hyperplasia, Lymphoid                                         1 (2%)                                             
      Mediastinal, Hyperplasia, Plasma Cell                                      1 (2%)                                             
      Mediastinal, Inflammation, Chronic Active                     1 (2%)                                                          
      Mediastinal, Lymphocyte, Necrosis, Acute                                   1 (2%)                                             
      Mesenteric, Hemorrhage, Acute                                              1 (2%)                                             
      Pancreatic, Thrombosis                                        1 (2%)                                                          
   Spleen                                             (50)         (50)         (50)                                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05038-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            DIMETHOXANE                                        Date: 09/05/94  
Route: GAVAGE                                                                                                     Time: 07:33:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      125 MG/      250 MG/                                                
                                                                KG           KG                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Fibrosis                                         1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 3 (6%)       3 (6%)       4 (8%)                                             
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Hyperplasia, Reticulum Cell                                                1 (2%)                                             
      Infarct, Chronic                                              1 (2%)                                                          
   Thymus                                             (41)         (38)         (41)                                                
      Cyst                                             3 (7%)                    2 (5%)                                             
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Necrosis                                                      1 (3%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (47)         (50)         (47)                                                
      Cyst                                                          2 (4%)                                                          
      Hyperplasia, Cystic                             47 (100%)    49 (98%)     43 (91%)                                            
   Skin                                               (50)         (50)         (50)                                                
      Acanthosis                                                    1 (2%)                                                          
      Cyst Epithelial Inclusion                                                  1 (2%)                                             
      Edema                                                                      1 (2%)                                             
      Hyperkeratosis                                                1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (49)         (50)                                                
      Compression                                      5 (10%)      8 (16%)      4 (8%)                                             
      Hemorrhage, Acute                                3 (6%)       2 (4%)       2 (4%)                                             
      Hydrocephalus                                    1 (2%)       9 (18%)      4 (8%)                                             
      Pigmentation, Hemosiderin                                                  1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)                                                
      Bacterium                                                                  1 (2%)                                             
      Foreign Body                                     2 (4%)       4 (8%)       6 (12%)                                            
      Inflammation, Chronic                           12 (24%)     11 (22%)     11 (22%)                                            
      Alveolar Epithelium, Hyperplasia                 3 (6%)                    2 (4%)                                             
      Mediastinum, Bacterium, Multiple                              1 (2%)       1 (2%)                                             
      Mediastinum, Foreign Body                                                  1 (2%)                                             
      Mediastinum, Hemorrhage, Acute                                             3 (6%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05038-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            DIMETHOXANE                                        Date: 09/05/94  
Route: GAVAGE                                                                                                     Time: 07:33:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/KG      125 MG/      250 MG/                                                
                                                                KG           KG                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Mediastinum, Inflammation, Chronic Active                     1 (2%)       7 (14%)                                            
      Pleura, Hyperplasia                                                        1 (2%)                                             
   Nose                                               (50)         (50)         (50)                                                
      Foreign Body                                     1 (2%)       7 (14%)      1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)       5 (10%)      3 (6%)                                             
      Nasolacrimal Duct, Inflammation, Suppurative     2 (4%)       3 (6%)       2 (4%)                                             
   Trachea                                            (50)         (50)         (50)                                                
      Foreign Body                                                               1 (2%)                                             
      Hemorrhage, Acute                                                          1 (2%)                                             
      Inflammation, Chronic Active                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)          (2)          (4)                                                 
      Hemorrhage, Acute                                1 (50%)                                                                      
      Lens, Cataract                                   1 (50%)      2 (100%)     2 (50%)                                            
      Retina, Atrophy                                  1 (50%)      2 (100%)     2 (50%)                                            
   Harderian Gland                                    (49)         (49)         (49)                                                
      Atrophy                                                       1 (2%)                                                          
      Inflammation, Chronic Active                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)                                                
      Cyst                                             1 (2%)                    1 (2%)                                             
      Infarct, Chronic                                 1 (2%)                    1 (2%)                                             
      Mineralization                                   3 (6%)       2 (4%)       1 (2%)                                             
      Nephropathy, Chronic                            38 (76%)     35 (70%)     26 (52%)                                            
   Urinary Bladder                                    (49)         (48)         (48)                                                
      Dilatation                                                                 1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05038-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            DIMETHOXANE                                        Date: 09/05/94  
Route: GAVAGE                                                                                                     Time: 07:33:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      62.5 MG/     125 MG/                                                
                                                                KG           KG                                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60                                                  
  Scheduled Sacrifice                                 10           10           10                                                  
  Early Deaths                                                                                                                      
    Moribund                                          21           15           12                                                  
    Dead                                               4            4            6                                                  
    Dosing Accident                                    2            3           11                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                23           28           21                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (49)         (50)         (50)                                                
      Hemorrhage, Acute                                             1 (2%)                                                          
      Inflammation, Chronic Active                                  2 (4%)       2 (4%)                                             
   Intestine Large, Colon                             (50)         (49)         (49)                                                
      Parasite Metazoan                                             3 (6%)       3 (6%)                                             
   Intestine Large, Rectum                            (49)         (47)         (47)                                                
      Parasite Metazoan                                6 (12%)      7 (15%)      3 (6%)                                             
   Intestine Small, Ileum                             (50)         (45)         (45)                                                
      Inflammation, Chronic Active                                               1 (2%)                                             
   Liver                                              (50)         (50)         (50)                                                
      Basophilic Focus                                24 (48%)     17 (34%)     18 (36%)                                            
      Clear Cell Focus                                 1 (2%)       2 (4%)                                                          
      Degeneration, Cystic                             2 (4%)       1 (2%)       3 (6%)                                             
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Hepatodiaphragmatic Nodule                       2 (4%)       1 (2%)       2 (4%)                                             
      Hyperplasia, Nodular                                          1 (2%)                                                          
      Inflammation, Chronic                           11 (22%)      6 (12%)     13 (26%)                                            
      Inflammation, Necrotizing                        1 (2%)                    2 (4%)                                             
      Necrosis, Coagulative                            1 (2%)       1 (2%)       1 (2%)                                             
      Vacuolization Cytoplasmic                                     1 (2%)       2 (4%)                                             
   Mesentery                                          (49)         (49)         (46)                                                
      Hemorrhage, Chronic                                           1 (2%)       1 (2%)                                             
      Inflammation, Chronic Active                     4 (8%)      13 (27%)      9 (20%)                                            
      Mineralization                                                3 (6%)       5 (11%)                                            
      Necrosis                                                                   1 (2%)                                             
   Pancreas                                           (50)         (50)         (50)                                                
      Ectopic Tissue                                                             1 (2%)                                             
      Inflammation, Chronic Active                     2 (4%)                    1 (2%)                                             
      Acinus, Atrophy                                 18 (36%)     22 (44%)     21 (42%)                                            
      Acinus, Hyperplasia                                           2 (4%)       1 (2%)                                             
      Duct, Ectasia                                    1 (2%)       2 (4%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05038-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            DIMETHOXANE                                        Date: 09/05/94  
Route: GAVAGE                                                                                                     Time: 07:33:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      62.5 MG/     125 MG/                                                
                                                                KG           KG                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Stomach, Forestomach                               (50)         (50)         (50)                                                
      Acanthosis, Focal                                5 (10%)      9 (18%)     23 (46%)                                            
      Edema                                            1 (2%)                                                                       
      Hyperkeratosis, Diffuse                                                    2 (4%)                                             
      Hyperkeratosis, Focal                            1 (2%)                    8 (16%)                                            
      Hyperplasia, Focal                               2 (4%)       1 (2%)       3 (6%)                                             
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                                                          
      Ulcer                                            1 (2%)                                                                       
   Stomach, Glandular                                 (50)         (49)         (50)                                                
      Inflammation, Chronic Active                     1 (2%)                                                                       
   Tooth                                              (50)         (49)         (50)                                                
      Dysplasia                                                     1 (2%)                                                          
      Inflammation, Chronic Active                     2 (4%)       1 (2%)       2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)                                                
      Cardiomyopathy, Chronic                         45 (90%)     48 (96%)     46 (92%)                                            
      Foreign Body                                                               2 (4%)                                             
      Inflammation, Chronic Active                                  2 (4%)       3 (6%)                                             
      Atrium, Thrombosis                               1 (2%)       5 (10%)      1 (2%)                                             
      Coronary Artery, Inflammation, Chronic Active                 1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (50)         (49)                                                
      Accessory Adrenal Cortical Nodule                1 (2%)                                                                       
      Atrophy                                                                    1 (2%)                                             
      Degeneration, Fatty                              5 (10%)      7 (14%)      7 (14%)                                            
      Hyperplasia                                     12 (24%)     19 (38%)     18 (37%)                                            
      Hypertrophy                                      1 (2%)       2 (4%)                                                          
      Necrosis, Coagulative                                                      1 (2%)                                             
   Adrenal Gland, Medulla                             (50)         (50)         (50)                                                
      Hyperplasia                                     13 (26%)     18 (36%)     13 (26%)                                            
   Islets, Pancreatic                                 (49)         (50)         (50)                                                
      Hyperplasia                                      1 (2%)                                                                       
   Pituitary Gland                                    (49)         (50)         (49)                                                
      Pars Distalis, Cyst                              6 (12%)      6 (12%)      9 (18%)                                            
      Pars Distalis, Hemorrhage, Acute                 1 (2%)                                                                       
      Pars Distalis, Hyperplasia                       9 (18%)      8 (16%)     11 (22%)                                            
      Pars Intermedia, Cyst                                                      1 (2%)                                             
   Thyroid Gland                                      (50)         (50)         (50)                                                
      Inflammation, Chronic Active                                               1 (2%)                                             
      C-Cell, Hyperplasia                             14 (28%)     16 (32%)     14 (28%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05038-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            DIMETHOXANE                                        Date: 09/05/94  
Route: GAVAGE                                                                                                     Time: 07:33:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      62.5 MG/     125 MG/                                                
                                                                KG           KG                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Follicle, Cyst                                                1 (2%)                                                          
      Follicular Cell, Hyperplasia                     5 (10%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                                      (1)                                                              
      Hemorrhage, Acute                                             1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (48)         (50)         (50)                                                
      Inflammation, Chronic Active                     2 (4%)                                                                       
   Preputial Gland                                    (48)         (47)         (49)                                                
      Hyperplasia                                      2 (4%)       4 (9%)       1 (2%)                                             
      Inflammation, Chronic Active                    45 (94%)     43 (91%)     42 (86%)                                            
      Duct, Ectasia                                                              2 (4%)                                             
   Prostate                                           (50)         (50)         (50)                                                
      Cyst                                             1 (2%)       2 (4%)                                                          
      Inflammation, Chronic Active                    24 (48%)     23 (46%)     22 (44%)                                            
   Seminal Vesicle                                    (48)         (49)         (48)                                                
      Inflammation, Chronic Active                                               1 (2%)                                             
   Testes                                             (50)         (50)         (50)                                                
      Cyst                                             1 (2%)                                                                       
      Hemorrhage, Chronic                                                        1 (2%)                                             
      Inflammation, Chronic Active                                               1 (2%)                                             
      Mineralization                                   8 (16%)     16 (32%)      7 (14%)                                            
      Interstitial Cell, Hyperplasia                  27 (54%)     33 (66%)     33 (66%)                                            
      Seminiferous Tubule, Atrophy                    40 (80%)     38 (76%)     34 (68%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)                                                
      Femoral, Hyperplasia, Reticulum Cell             1 (2%)                    2 (4%)                                             
      Femoral, Myelofibrosis                           2 (4%)                                                                       
   Lymph Node                                         (50)         (50)         (50)                                                
      Mediastinal, Cyst                                                          1 (2%)                                             
      Mediastinal, Edema, Acute                                                  1 (2%)                                             
      Mediastinal, Hemorrhage, Acute                                             1 (2%)                                             
   Lymph Node, Mandibular                             (50)         (50)         (49)                                                
      Cyst                                                          6 (12%)      2 (4%)                                             
      Hyperplasia, Plasma Cell                                      1 (2%)                                                          
   Spleen                                             (50)         (50)         (50)                                                
      Fibrosis                                         3 (6%)       2 (4%)       2 (4%)                                             
      Hematopoietic Cell Proliferation                 1 (2%)       1 (2%)       3 (6%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05038-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            DIMETHOXANE                                        Date: 09/05/94  
Route: GAVAGE                                                                                                     Time: 07:33:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      62.5 MG/     125 MG/                                                
                                                                KG           KG                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Infarct, Chronic                                              1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (42)         (43)         (42)                                                
      Hyperplasia, Cystic                             38 (90%)     43 (100%)    39 (93%)                                            
      Inflammation, Chronic Active                                               1 (2%)                                             
   Skin                                               (50)         (50)         (50)                                                
      Acanthosis                                       1 (2%)       1 (2%)       1 (2%)                                             
      Fibrosis                                         1 (2%)                                                                       
      Hyperkeratosis                                   2 (4%)       3 (6%)       2 (4%)                                             
      Inflammation, Chronic Active                     3 (6%)       2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)                                                
      Compression                                      7 (14%)      3 (6%)       4 (8%)                                             
      Hemorrhage, Acute                                3 (6%)       1 (2%)       1 (2%)                                             
      Hydrocephalus                                    7 (14%)      3 (6%)       3 (6%)                                             
      Necrosis                                         1 (2%)                                                                       
   Spinal Cord                                                     (1)                                                              
      White Matter, Degeneration                                    1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)                                                
      Bacterium, Multiple                                                        1 (2%)                                             
      Foreign Body                                     2 (4%)       6 (12%)      9 (18%)                                            
      Inflammation, Chronic                           21 (42%)     11 (22%)     15 (30%)                                            
      Alveolar Epithelium, Hyperplasia                 4 (8%)       5 (10%)      3 (6%)                                             
      Mediastinum, Hemorrhage, Acute                                1 (2%)                                                          
      Mediastinum, Inflammation, Chronic Active                     2 (4%)       4 (8%)                                             
   Nose                                               (50)         (48)         (50)                                                
      Fibrosis                                                      1 (2%)                                                          
      Foreign Body                                                  9 (19%)                                                         
      Inflammation, Chronic Active                     2 (4%)       6 (13%)      1 (2%)                                             
      Nasolacrimal Duct, Inflammation, Chronic                                                                                      
          Active                                                    1 (2%)                                                          
      Nasolacrimal Duct, Inflammation, Suppurative     3 (6%)       3 (6%)       2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05038-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            DIMETHOXANE                                        Date: 09/05/94  
Route: GAVAGE                                                                                                     Time: 07:33:28  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/KG      62.5 MG/     125 MG/                                                
                                                                KG           KG                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
   Trachea                                            (49)         (50)         (50)                                                
      Hemorrhage, Acute                                             1 (2%)                                                          
      Inflammation, Chronic Active                                  2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                                          (1)                                                 
      Acanthosis                                                                 1 (100%)                                           
      Hyperkeratosis                                                             1 (100%)                                           
   Eye                                                (3)          (2)          (5)                                                 
      Lens, Cataract                                   3 (100%)     1 (50%)      1 (20%)                                            
      Retina, Atrophy                                  3 (100%)     1 (50%)      1 (20%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)                                                
      Cyst                                                          1 (2%)       2 (4%)                                             
      Hemorrhage, Chronic                                           1 (2%)                                                          
      Infarct, Chronic                                                           1 (2%)                                             
      Inflammation, Necrotizing                        1 (2%)                                                                       
      Mineralization                                                             1 (2%)                                             
      Nephropathy, Chronic                            47 (94%)     49 (98%)     47 (94%)                                            
   Urinary Bladder                                    (49)         (49)         (49)                                                
      Dilatation                                       1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 72963-72963/72963


--multipart-boundary--